[
  {
    "title": "柳药集团(603368.SH)：截至12月底已累计回购146.36万股",
    "href": "http://stock.jrj.com.cn/2023/01/03205537256647.shtml",
    "datetime": "2023-01-03 20:55:27",
    "code": "603368"
  },
  {
    "title": "柳药集团(603368.SH)：控股股东朱朝阳质押1250万股",
    "href": "http://stock.jrj.com.cn/2022/12/26163137238221.shtml",
    "datetime": "2022-12-26 16:31:20",
    "code": "603368"
  },
  {
    "title": "柳药集团(603368.SH)：12月14日首次回购48.91万股",
    "href": "http://stock.jrj.com.cn/2022/12/14163937212105.shtml",
    "datetime": "2022-12-14 16:39:08",
    "code": "603368"
  },
  {
    "title": "柳药集团(603368.SH)：尚未回购公司股份",
    "href": "http://stock.jrj.com.cn/2022/12/02163937184651.shtml",
    "datetime": "2022-12-02 16:39:07",
    "code": "603368"
  },
  {
    "title": "柳药集团(603368.SH)：控股股东朱朝阳解质1512万股",
    "href": "http://stock.jrj.com.cn/2022/11/18160137150057.shtml",
    "datetime": "2022-11-18 16:01:22",
    "code": "603368"
  },
  {
    "title": "柳药集团控股股东朱朝阳质押1400万股 用于置换原有股份质押融资",
    "href": "http://stock.jrj.com.cn/2022/11/15205237141704.shtml",
    "datetime": "2022-11-15 20:52:52",
    "code": "603368"
  },
  {
    "title": "柳药集团(603368.SH)：控股股东朱朝阳质押1400万股",
    "href": "http://stock.jrj.com.cn/2022/11/15180737141006.shtml",
    "datetime": "2022-11-15 18:07:48",
    "code": "603368"
  },
  {
    "title": "柳药集团(603368.SH)：拟斥0.5亿元-1亿元回购公司股份",
    "href": "http://stock.jrj.com.cn/2022/11/14170937137373.shtml",
    "datetime": "2022-11-14 17:09:05",
    "code": "603368"
  },
  {
    "title": "柳药集团2022年前三季度净利5.75亿同比增长15.42% 药品销售规模稳中有升",
    "href": "http://stock.jrj.com.cn/2022/10/26225037087724.shtml",
    "datetime": "2022-10-26 22:50:38",
    "code": "603368"
  },
  {
    "title": "柳药集团(603368.SH)业绩快报：前三季度净利5.75亿元 同比增长15.4%",
    "href": "http://stock.jrj.com.cn/2022/10/16163537058317.shtml",
    "datetime": "2022-10-16 16:35:54",
    "code": "603368"
  },
  {
    "title": "柳药集团：上半年净利3.69亿元 同比增长12.04%",
    "href": "http://stock.jrj.com.cn/2022/08/17160536908016.shtml",
    "datetime": "2022-08-17 16:05:26",
    "code": "603368"
  },
  {
    "title": "柳药集团(603368.SH)上半年净利3.69亿元，同比增长12.04%",
    "href": "http://stock.jrj.com.cn/2022/08/17160036908039.shtml",
    "datetime": "2022-08-17 16:00:58",
    "code": "603368"
  },
  {
    "title": "柳药集团(603368.SH)2021年度权益分派10派4.8元 股权登记日为6月16日",
    "href": "http://stock.jrj.com.cn/2022/06/09190136716829.shtml",
    "datetime": "2022-06-09 19:01:11",
    "code": "603368"
  },
  {
    "title": "柳药股份(603368.SH)：证券简称将于5月27日起变更为“柳药集团”",
    "href": "http://stock.jrj.com.cn/2022/05/23185636671321.shtml",
    "datetime": "2022-05-23 18:56:20",
    "code": "603368"
  },
  {
    "title": "柳药股份2022年第一季度净利2.21亿同比增长6.35% 批发业务规模稳健增长",
    "href": "http://stock.jrj.com.cn/2022/05/03191136546536.shtml",
    "datetime": "2022-05-03 19:11:51",
    "code": "603368"
  },
  {
    "title": "柳药股份(603368.SH)：一季度净利润增6.35%至2.21亿元",
    "href": "http://stock.jrj.com.cn/2022/04/27212436486701.shtml",
    "datetime": "2022-04-27 21:24:55",
    "code": "603368"
  },
  {
    "title": "柳药股份2021年净利5.64亿同比下滑20.78% 董事长朱朝阳薪酬62万",
    "href": "http://stock.jrj.com.cn/2022/03/31141036237675.shtml",
    "datetime": "2022-03-31 14:10:53",
    "code": "603368"
  },
  {
    "title": "柳药股份(603368.SH)：拟变更公司名称为“广西柳药集团股份有限公司”、证券简称为“柳药集团”",
    "href": "http://stock.jrj.com.cn/2022/03/31011736214534.shtml",
    "datetime": "2022-03-31 01:17:11",
    "code": "603368"
  },
  {
    "title": "柳药股份(603368.SH)：2021年度净利降20.78%至5.64亿元 拟10派4.8元",
    "href": "http://stock.jrj.com.cn/2022/03/30181636200757.shtml",
    "datetime": "2022-03-30 18:16:50",
    "code": "603368"
  },
  {
    "title": "柳药股份(603368.SH)：不向下修正“柳药转债”的转股价",
    "href": "http://stock.jrj.com.cn/2022/03/14170534824403.shtml",
    "datetime": "2022-03-14 17:05:55",
    "code": "603368"
  },
  {
    "title": "A股异动 | 柳药股份(603368.SH)涨停 公司是辉瑞抗生素产品在广西区内的主经销商",
    "href": "http://stock.jrj.com.cn/2022/03/04144034522065.shtml",
    "datetime": "2022-03-04 14:40:27",
    "code": "603368"
  },
  {
    "title": "柳药股份(603368.SH)：第一期员工持股计划存续期延长12个月",
    "href": "http://stock.jrj.com.cn/2022/02/10154634318199.shtml",
    "datetime": "2022-02-10 15:46:57",
    "code": "603368"
  },
  {
    "title": "柳药股份(603368.SH)：拟将部分募投项目延期",
    "href": "http://stock.jrj.com.cn/2022/01/21200234184023.shtml",
    "datetime": "2022-01-21 20:02:30",
    "code": "603368"
  },
  {
    "title": "【龙虎榜】柳药股份1月11日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/11180934146940.shtml",
    "datetime": "2022-01-11 18:09:10",
    "code": "603368"
  },
  {
    "title": "柳药股份(603368.SH)：仙茱制药取得药品生产许可证",
    "href": "http://stock.jrj.com.cn/2021/12/28164534076563.shtml",
    "datetime": "2021-12-28 16:45:18",
    "code": "603368"
  },
  {
    "title": "柳药股份控股股东朱朝阳质押830万股 用于补充质押",
    "href": "http://stock.jrj.com.cn/2021/12/24193334059194.shtml",
    "datetime": "2021-12-24 19:33:00",
    "code": "603368"
  },
  {
    "title": "柳药股份(603368.SH)：实控人质押的合计3962万股延期购回并补充质押830万股",
    "href": "http://stock.jrj.com.cn/2021/12/24165034058150.shtml",
    "datetime": "2021-12-24 16:50:33",
    "code": "603368"
  },
  {
    "title": "柳药股份(603368.SH)：第三季度净利降20.89%至1.69亿元",
    "href": "http://stock.jrj.com.cn/2021/10/26170633755211.shtml",
    "datetime": "2021-10-26 17:06:08",
    "code": "603368"
  },
  {
    "title": "创新打造数字化中药产业 柳药股份推出国内首个开放式中医药产业联盟链平台",
    "href": "http://stock.jrj.com.cn/2021/10/19132533715918.shtml",
    "datetime": "2021-10-19 13:25:05",
    "code": "603368"
  },
  {
    "title": "柳药股份：互联网技术赋能 旗下医院获批互联网医院资质",
    "href": "http://stock.jrj.com.cn/2021/09/15195333441242.shtml",
    "datetime": "2021-09-15 19:53:09",
    "code": "603368"
  },
  {
    "title": "柳药股份上市六年净利首降16% 股价跌六成股权激励恐“失效”",
    "href": "http://stock.jrj.com.cn/2021/08/20074433284827.shtml",
    "datetime": "2021-08-20 07:44:07",
    "code": "603368"
  },
  {
    "title": "【龙虎榜】柳药股份8月19日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/08/19180733281521.shtml",
    "datetime": "2021-08-19 18:07:25",
    "code": "603368"
  },
  {
    "title": "柳药股份发业绩股价跌停 上半年净利降17%ROE下降",
    "href": "http://stock.jrj.com.cn/2021/08/19164933280930.shtml",
    "datetime": "2021-08-19 16:49:00",
    "code": "603368"
  },
  {
    "title": "A股异动 | 柳药股份(603368.SH)放量跌停 上半年净利降16.58%",
    "href": "http://stock.jrj.com.cn/2021/08/19111433278929.shtml",
    "datetime": "2021-08-19 11:14:54",
    "code": "603368"
  },
  {
    "title": "柳药股份2021年半年度净利3.29亿元 同比净利减少16.58%",
    "href": "http://stock.jrj.com.cn/2021/08/18214633276098.shtml",
    "datetime": "2021-08-18 21:46:47",
    "code": "603368"
  },
  {
    "title": "柳药股份(603368.SH)：上半年净利降16.58%至3.29亿元",
    "href": "http://stock.jrj.com.cn/2021/08/18211833275938.shtml",
    "datetime": "2021-08-18 21:18:12",
    "code": "603368"
  },
  {
    "title": "柳药股份拟对外投资2500万元设立合资公司 持股50%",
    "href": "http://stock.jrj.com.cn/2021/07/28215133165958.shtml",
    "datetime": "2021-07-28 21:51:59",
    "code": "603368"
  },
  {
    "title": "柳药股份(603368.SH)拟出资2500万元参设合资公司 拓展高品质医学影像设备产业",
    "href": "http://stock.jrj.com.cn/2021/07/28164633164381.shtml",
    "datetime": "2021-07-28 16:46:59",
    "code": "603368"
  },
  {
    "title": "柳药股份(603368.SH)：约153.43万股限制性股票7月16日解锁上市",
    "href": "http://stock.jrj.com.cn/2021/07/12192233083923.shtml",
    "datetime": "2021-07-12 19:22:37",
    "code": "603368"
  },
  {
    "title": "柳药股份：公司的零售药店目前以租赁为主",
    "href": "http://stock.jrj.com.cn/2021/06/21203632971436.shtml",
    "datetime": "2021-06-21 20:36:18",
    "code": "603368"
  },
  {
    "title": "柳药股份(603368.SH)：控股股东解质581万股",
    "href": "http://stock.jrj.com.cn/2021/06/18160532954826.shtml",
    "datetime": "2021-06-18 16:05:26",
    "code": "603368"
  },
  {
    "title": "柳药股份：目前公司各业务板块发展一切正常",
    "href": "http://stock.jrj.com.cn/2021/06/17205932949644.shtml",
    "datetime": "2021-06-17 20:59:12",
    "code": "603368"
  },
  {
    "title": "柳药股份：公司具备广西区内麻醉药品、精神药品的经营资质",
    "href": "http://stock.jrj.com.cn/2021/06/15201932936547.shtml",
    "datetime": "2021-06-15 20:19:49",
    "code": "603368"
  },
  {
    "title": "柳药股份(603368.SH)：不向下修正“柳药转债”的转股价",
    "href": "http://stock.jrj.com.cn/2021/06/11222732914231.shtml",
    "datetime": "2021-06-11 22:27:13",
    "code": "603368"
  },
  {
    "title": "柳药股份(603368.SH)：2020年度拟10派6元 6月9日股权登记",
    "href": "http://stock.jrj.com.cn/2021/06/02195732865118.shtml",
    "datetime": "2021-06-02 19:57:52",
    "code": "603368"
  },
  {
    "title": "柳药股份：公司2020年度研发费用为874.21万元主要是子公司仙茱中药科技和万通制药对研发新产品的支出",
    "href": "http://stock.jrj.com.cn/2021/05/31201732852143.shtml",
    "datetime": "2021-05-31 20:17:24",
    "code": "603368"
  },
  {
    "title": "柳药股份：“万通筋骨贴”并非我公司旗下广西万通制药有限公司的产品",
    "href": "http://stock.jrj.com.cn/2021/05/31200432852074.shtml",
    "datetime": "2021-05-31 20:04:08",
    "code": "603368"
  },
  {
    "title": "柳药股份：公司旗下拥有仙茱中药科技、万通制药、康晟制药等三家药品生产企业",
    "href": "http://stock.jrj.com.cn/2021/05/27161432830095.shtml",
    "datetime": "2021-05-27 16:14:32",
    "code": "603368"
  },
  {
    "title": "柳药股份(603368.SH)：一季度净利升12.29%至2.08亿元",
    "href": "http://stock.jrj.com.cn/2021/04/27185432464775.shtml",
    "datetime": "2021-04-27 18:54:10",
    "code": "603368"
  },
  {
    "title": "柳药股份：公司已开展中药饮片生产工艺和质量标准研究、中成药专利申请和相关研发工作等",
    "href": "http://stock.jrj.com.cn/2021/04/07191132326709.shtml",
    "datetime": "2021-04-07 19:11:10",
    "code": "603368"
  },
  {
    "title": "柳药股份：公司并不直接与临床科室开展业务",
    "href": "http://stock.jrj.com.cn/2021/04/07185932326663.shtml",
    "datetime": "2021-04-07 18:59:30",
    "code": "603368"
  },
  {
    "title": "柳药股份：公司医院销售业务覆盖广西三甲医院",
    "href": "http://stock.jrj.com.cn/2021/04/07185532326625.shtml",
    "datetime": "2021-04-07 18:55:45",
    "code": "603368"
  },
  {
    "title": "柳药股份：目前未涉及期货相关业务",
    "href": "http://stock.jrj.com.cn/2021/03/31120532254887.shtml",
    "datetime": "2021-03-31 12:05:19",
    "code": "603368"
  },
  {
    "title": "柳药股份2020年净利增长3.84% 董事长朱朝阳薪酬57万",
    "href": "http://stock.jrj.com.cn/2021/03/29232132243913.shtml",
    "datetime": "2021-03-29 23:21:44",
    "code": "603368"
  },
  {
    "title": "柳药股份(603368.SH)2020年度净利润升3.84%至7.12亿元 拟10派6元",
    "href": "http://stock.jrj.com.cn/2021/03/29193532242822.shtml",
    "datetime": "2021-03-29 19:35:50",
    "code": "603368"
  },
  {
    "title": "柳药股份2020年度净利7.16亿增长4.42% 零售业务增长较快",
    "href": "http://stock.jrj.com.cn/2021/02/24204332020445.shtml",
    "datetime": "2021-02-24 20:43:27",
    "code": "603368"
  },
  {
    "title": "柳药股份：公司零售板块继续保持较快增长",
    "href": "http://stock.jrj.com.cn/2021/02/08171531870939.shtml",
    "datetime": "2021-02-08 17:15:55",
    "code": "603368"
  },
  {
    "title": "柳药股份(603368.SH)：第一期员工持股计划延期",
    "href": "http://stock.jrj.com.cn/2021/02/04164231849141.shtml",
    "datetime": "2021-02-04 16:42:42",
    "code": "603368"
  },
  {
    "title": "柳药股份(603368.SH)：聘任苏春燕担任公司财务总监",
    "href": "http://stock.jrj.com.cn/2021/01/23171231749443.shtml",
    "datetime": "2021-01-23 17:12:47",
    "code": "603368"
  },
  {
    "title": "柳药股份(603368.SH)：控股股东质押展期1743万股",
    "href": "http://stock.jrj.com.cn/2021/01/12161331676661.shtml",
    "datetime": "2021-01-12 16:13:30",
    "code": "603368"
  },
  {
    "title": "柳药股份：公司与腾讯公司等科技企业及相关平台搭建方建立合作",
    "href": "http://stock.jrj.com.cn/2021/01/11182431671482.shtml",
    "datetime": "2021-01-11 18:24:52",
    "code": "603368"
  },
  {
    "title": "柳药股份：现阶段公司仍然重点加快在广西区内的零售门店布局",
    "href": "http://stock.jrj.com.cn/2021/01/05183931635757.shtml",
    "datetime": "2021-01-05 18:39:08",
    "code": "603368"
  },
  {
    "title": "柳药股份前三季度净利6.08亿增长11.13% 其他收益同比增长",
    "href": "http://stock.jrj.com.cn/2020/10/28094231148941.shtml",
    "datetime": "2020-10-28 09:42:23",
    "code": "603368"
  },
  {
    "title": "柳药股份：2020年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/10/28001131145454.shtml",
    "datetime": "2020-10-28 00:11:31",
    "code": "603368"
  },
  {
    "title": "柳药股份2020年上半年净利3.95亿增长10.87% 药品流通市场规模稳步增长",
    "href": "http://stock.jrj.com.cn/2020/08/19222830541616.shtml",
    "datetime": "2020-08-19 22:28:06",
    "code": "603368"
  },
  {
    "title": "柳药股份半年报：上半年净利3.95亿元 同比增11%",
    "href": "http://stock.jrj.com.cn/2020/08/19173330539982.shtml",
    "datetime": "2020-08-19 17:33:31",
    "code": "603368"
  },
  {
    "title": "柳药股份2020年上半年净利4亿增长11% DTP药店业务增长良好",
    "href": "http://stock.jrj.com.cn/2020/08/05120230430984.shtml",
    "datetime": "2020-08-05 12:02:46",
    "code": "603368"
  },
  {
    "title": "柳药股份上半年净利润同比增逾10%",
    "href": "http://stock.jrj.com.cn/2020/07/31195330395813.shtml",
    "datetime": "2020-07-31 19:53:31",
    "code": "603368"
  },
  {
    "title": "柳药股份：业务技术能够满足疫苗等需冷链品种的配送",
    "href": "http://stock.jrj.com.cn/2020/07/31104630391789.shtml",
    "datetime": "2020-07-31 10:46:56",
    "code": "603368"
  },
  {
    "title": "柳药股份3名股东合计减持113.39万股 套现约3133.05万元",
    "href": "http://stock.jrj.com.cn/2020/07/29185730375037.shtml",
    "datetime": "2020-07-29 18:57:50",
    "code": "603368"
  },
  {
    "title": "柳药股份与八桂皮肤科医生签订战略合作协议",
    "href": "http://stock.jrj.com.cn/2020/07/16195930263685.shtml",
    "datetime": "2020-07-16 19:59:47",
    "code": "603368"
  },
  {
    "title": "柳药股份：拟与八桂皮肤科医生战略合作",
    "href": "http://stock.jrj.com.cn/2020/07/16184430263063.shtml",
    "datetime": "2020-07-16 18:44:31",
    "code": "603368"
  },
  {
    "title": "柳药股份：2019年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2020/06/17232029952056.shtml",
    "datetime": "2020-06-17 23:20:03",
    "code": "603368"
  },
  {
    "title": "柳药股份第一季度盈利1.85亿同比增长15.30% 政府补助增加",
    "href": "http://stock.jrj.com.cn/2020/04/23195129360243.shtml",
    "datetime": "2020-04-23 19:51:27",
    "code": "603368"
  },
  {
    "title": "柳药股份：2019年净利同比增30% 拟10转4派6.8元",
    "href": "http://stock.jrj.com.cn/2020/04/23040829353057.shtml",
    "datetime": "2020-04-23 04:08:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：2020年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/03/31023029150911.shtml",
    "datetime": "2020-03-31 02:30:04",
    "code": "603368"
  },
  {
    "title": "柳药股份：第四届董事会第一次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/03/31023029150912.shtml",
    "datetime": "2020-03-31 02:30:04",
    "code": "603368"
  },
  {
    "title": "柳药股份：第三届董事会第二十六次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/03/13234029023443.shtml",
    "datetime": "2020-03-13 23:40:14",
    "code": "603368"
  },
  {
    "title": "柳药股份：关于召开2020年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/03/13234029023344.shtml",
    "datetime": "2020-03-13 23:40:00",
    "code": "603368"
  },
  {
    "title": "柳药股份股东肖俊雄减持22万股 套现约786万元",
    "href": "http://stock.jrj.com.cn/2020/03/10200228993567.shtml",
    "datetime": "2020-03-10 20:02:31",
    "code": "603368"
  },
  {
    "title": "[柳药股份]鄂桂齐心、共克时艰,柳药股份助力本土自产医用防护服、隔离衣驰援湖北防疫一线",
    "href": "http://stock.jrj.com.cn/2020/02/20000028871206.shtml",
    "datetime": "2020-02-20 00:00:00",
    "code": "603368"
  },
  {
    "title": "[柳药股份]自治区党委副书记、自治区人民政府主席、党组书记陈武莅临柳药股份指导疫情防控工作",
    "href": "http://stock.jrj.com.cn/2020/02/18000028871205.shtml",
    "datetime": "2020-02-18 00:00:00",
    "code": "603368"
  },
  {
    "title": "[柳药股份]柳药股份第四批支援湖北医疗队的救援物资奔赴前线",
    "href": "http://stock.jrj.com.cn/2020/02/17000028871207.shtml",
    "datetime": "2020-02-17 00:00:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：有经营阿比多尔、达芦那韦 渠道稳定",
    "href": "http://stock.jrj.com.cn/2020/02/05101628774299.shtml",
    "datetime": "2020-02-05 10:16:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：是广西指定口罩、防护服等防疫药械定点供应单位",
    "href": "http://stock.jrj.com.cn/2020/02/04103028764622.shtml",
    "datetime": "2020-02-04 10:30:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：柳药转债中签号出炉 共285496个",
    "href": "http://stock.jrj.com.cn/2020/01/19141528701212.shtml",
    "datetime": "2020-01-19 14:15:16",
    "code": "603368"
  },
  {
    "title": "柳药股份：柳药转债网上中签率为0.00937384％",
    "href": "http://stock.jrj.com.cn/2020/01/16210728688702.shtml",
    "datetime": "2020-01-16 21:07:47",
    "code": "603368"
  },
  {
    "title": "柳药股份股东朱朝阳质押200万股 用于认购可转债",
    "href": "http://stock.jrj.com.cn/2020/01/15231428683179.shtml",
    "datetime": "2020-01-15 23:14:06",
    "code": "603368"
  },
  {
    "title": "柳药股份：第三届董事会第二十四次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/01/13225028669494.shtml",
    "datetime": "2020-01-13 22:50:03",
    "code": "603368"
  },
  {
    "title": "柳药股份：公开发行可转换公司债券发行公告",
    "href": "http://stock.jrj.com.cn/2020/01/13225028669495.shtml",
    "datetime": "2020-01-13 22:50:03",
    "code": "603368"
  },
  {
    "title": "柳药股份业绩预增38.21%医药工业板块是新增长点",
    "href": "http://stock.jrj.com.cn/2020/01/13073128665036.shtml",
    "datetime": "2020-01-13 07:31:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：2019年年度业绩预增公告",
    "href": "http://stock.jrj.com.cn/2020/01/10214028660197.shtml",
    "datetime": "2020-01-10 21:40:09",
    "code": "603368"
  },
  {
    "title": "柳药股份：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/10194028659722.shtml",
    "datetime": "2020-01-10 19:40:01",
    "code": "603368"
  },
  {
    "title": "柳药股份2019年净利预增29%-38%",
    "href": "http://stock.jrj.com.cn/2020/01/10183628658992.shtml",
    "datetime": "2020-01-10 18:36:42",
    "code": "603368"
  },
  {
    "title": "柳药股份2019年度预计实现净利6.8亿元到7.3亿元",
    "href": "http://stock.jrj.com.cn/2020/01/10182128658912.shtml",
    "datetime": "2020-01-10 18:21:08",
    "code": "603368"
  },
  {
    "title": "柳药股份：2019年度净利同比预增29%-38%",
    "href": "http://stock.jrj.com.cn/2020/01/10181728658888.shtml",
    "datetime": "2020-01-10 18:17:49",
    "code": "603368"
  },
  {
    "title": "柳药股份：预计2019年实现归母净利6.8亿元至7.3亿元",
    "href": "http://stock.jrj.com.cn/2020/01/10174028658701.shtml",
    "datetime": "2020-01-10 17:40:39",
    "code": "603368"
  },
  {
    "title": "柳药股份：2019年度净利预增29%到38%",
    "href": "http://stock.jrj.com.cn/2020/01/10171828658610.shtml",
    "datetime": "2020-01-10 17:18:00",
    "code": "603368"
  },
  {
    "title": "柳药股份股东朱朝阳质押2490万股 2019年前三季度净利同比增长40%",
    "href": "http://stock.jrj.com.cn/2020/01/08211028645553.shtml",
    "datetime": "2020-01-08 21:10:48",
    "code": "603368"
  },
  {
    "title": "柳药股份4名股东拟减持股份 预计合计减持不超总股本0.48%",
    "href": "http://stock.jrj.com.cn/2020/01/03213828626435.shtml",
    "datetime": "2020-01-03 21:38:34",
    "code": "603368"
  },
  {
    "title": "柳药股份前三季度盈利5.48亿 同比增长40.10%",
    "href": "http://stock.jrj.com.cn/2019/10/30083228323085.shtml",
    "datetime": "2019-10-30 08:32:48",
    "code": "603368"
  },
  {
    "title": "柳药股份：2019年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/10/30011028321064.shtml",
    "datetime": "2019-10-30 01:10:05",
    "code": "603368"
  },
  {
    "title": "柳药股份：公司可转债发行申请获证监会审核通过",
    "href": "http://stock.jrj.com.cn/2019/10/13160328238788.shtml",
    "datetime": "2019-10-13 16:03:43",
    "code": "603368"
  },
  {
    "title": "柳药股份：可转债发行申请获证监会审核通过",
    "href": "http://stock.jrj.com.cn/2019/10/13153228238764.shtml",
    "datetime": "2019-10-13 15:32:00",
    "code": "603368"
  },
  {
    "title": "柳药股份股东九泰基金减持564万股 套现约1.96亿元",
    "href": "http://stock.jrj.com.cn/2019/10/11215528235412.shtml",
    "datetime": "2019-10-11 21:55:43",
    "code": "603368"
  },
  {
    "title": "[柳药股份]柳药股份举行 “庆祝建国七十周年” 职工才艺大赛",
    "href": "http://stock.jrj.com.cn/2019/09/23000028267374.shtml",
    "datetime": "2019-09-23 00:00:00",
    "code": "603368"
  },
  {
    "title": "[柳药股份]第十三届“柳药杯”气排球邀请赛圆满落幕",
    "href": "http://stock.jrj.com.cn/2019/08/21000028011634.shtml",
    "datetime": "2019-08-21 00:00:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：2019年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/08/13004027964683.shtml",
    "datetime": "2019-08-13 00:40:18",
    "code": "603368"
  },
  {
    "title": "柳药股份：第三届董事会第二十二次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/08/13004027964684.shtml",
    "datetime": "2019-08-13 00:40:18",
    "code": "603368"
  },
  {
    "title": "柳药股份：上半年净利3.56亿元 同比增长39%",
    "href": "http://stock.jrj.com.cn/2019/08/12200527963954.shtml",
    "datetime": "2019-08-12 20:05:37",
    "code": "603368"
  },
  {
    "title": "柳药股份2019年上半年净利3.56亿 毛利率提升",
    "href": "http://stock.jrj.com.cn/2019/08/12185727963738.shtml",
    "datetime": "2019-08-12 18:57:14",
    "code": "603368"
  },
  {
    "title": "柳药股份：上半年净利3.56亿元 同比增39%",
    "href": "http://stock.jrj.com.cn/2019/08/12184727963711.shtml",
    "datetime": "2019-08-12 18:47:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：第三届董事会第二十一次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/08/09112027952884.shtml",
    "datetime": "2019-08-09 11:20:05",
    "code": "603368"
  },
  {
    "title": "柳药股份业绩快报：上半年净利同比增39%",
    "href": "http://stock.jrj.com.cn/2019/07/18172427857953.shtml",
    "datetime": "2019-07-18 17:24:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：上半年净利3.56亿元 同比增长39%",
    "href": "http://stock.jrj.com.cn/2019/07/18170627857773.shtml",
    "datetime": "2019-07-18 17:06:18",
    "code": "603368"
  },
  {
    "title": "柳药股份业绩快报：上半年净利3.57亿元 同比增39.36％",
    "href": "http://stock.jrj.com.cn/2019/07/18170527857766.shtml",
    "datetime": "2019-07-18 17:05:49",
    "code": "603368"
  },
  {
    "title": "[柳药股份]缅怀革命先烈 弘扬长征精神——公司开展纪念建党98周年长征主题教育活动",
    "href": "http://stock.jrj.com.cn/2019/07/09000028011633.shtml",
    "datetime": "2019-07-09 00:00:00",
    "code": "603368"
  },
  {
    "title": "[柳药股份]柳药股份第四届“悦运动,享健康”徒步活动成功举办",
    "href": "http://stock.jrj.com.cn/2019/06/17000028011635.shtml",
    "datetime": "2019-06-17 00:00:00",
    "code": "603368"
  },
  {
    "title": "[柳药股份]柳药股份2019年度“万邦杯”男子篮球赛圆满成功",
    "href": "http://stock.jrj.com.cn/2019/06/17000028011636.shtml",
    "datetime": "2019-06-17 00:00:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：2018年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2019/05/21222027603266.shtml",
    "datetime": "2019-05-21 22:20:05",
    "code": "603368"
  },
  {
    "title": "柳药股份一季度净利1.6亿元同比增长42% 现金流量净额为-3亿元",
    "href": "http://stock.jrj.com.cn/2019/05/05081927522711.shtml",
    "datetime": "2019-05-05 08:19:23",
    "code": "603368"
  },
  {
    "title": "柳药股份：2018年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/04/30102027512566.shtml",
    "datetime": "2019-04-30 10:20:23",
    "code": "603368"
  },
  {
    "title": "柳药股份：2019年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/04/30102027512565.shtml",
    "datetime": "2019-04-30 10:20:23",
    "code": "603368"
  },
  {
    "title": "柳药股份一季度净利1.6亿元 同比增41.68%",
    "href": "http://stock.jrj.com.cn/2019/04/21173327442782.shtml",
    "datetime": "2019-04-21 17:33:42",
    "code": "603368"
  },
  {
    "title": "柳药股份：股东九泰基金违规减持并致歉",
    "href": "http://stock.jrj.com.cn/2019/04/14160027385759.shtml",
    "datetime": "2019-04-14 16:00:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：第三届董事会第十七次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/04/04214027323028.shtml",
    "datetime": "2019-04-04 21:40:08",
    "code": "603368"
  },
  {
    "title": "柳药股份：关于召开2018年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2019/04/04214027323029.shtml",
    "datetime": "2019-04-04 21:40:08",
    "code": "603368"
  },
  {
    "title": "柳药股份拟公开发行不超10亿元可转债拓展主业",
    "href": "http://stock.jrj.com.cn/2019/04/04212227331511.shtml",
    "datetime": "2019-04-04 21:22:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：拟发行可转债募资不超10亿元",
    "href": "http://stock.jrj.com.cn/2019/04/04191327322436.shtml",
    "datetime": "2019-04-04 19:13:36",
    "code": "603368"
  },
  {
    "title": "柳药股份2018年净利润增逾31% 拟10股派6.2元",
    "href": "http://stock.jrj.com.cn/2019/03/28143627258426.shtml",
    "datetime": "2019-03-28 14:36:16",
    "code": "603368"
  },
  {
    "title": "柳药股份净利润增长32%：两票制提升行业集中度 制药业务成新增长引擎",
    "href": "http://stock.jrj.com.cn/2019/03/28111727257319.shtml",
    "datetime": "2019-03-28 11:17:09",
    "code": "603368"
  },
  {
    "title": "柳药股份：2018年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/03/27234027253365.shtml",
    "datetime": "2019-03-27 23:40:13",
    "code": "603368"
  },
  {
    "title": "柳药股份：第三届董事会第十六次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/03/27234027253366.shtml",
    "datetime": "2019-03-27 23:40:13",
    "code": "603368"
  },
  {
    "title": "柳药股份：2018年净利同比增长32% 拟10派6.2元",
    "href": "http://stock.jrj.com.cn/2019/03/27225227253135.shtml",
    "datetime": "2019-03-27 22:52:00",
    "code": "603368"
  },
  {
    "title": "[柳药股份]智变超越 使命担当——柳药股份2019年销售年会成功举办",
    "href": "http://stock.jrj.com.cn/2019/03/03000028065149.shtml",
    "datetime": "2019-03-03 00:00:00",
    "code": "603368"
  },
  {
    "title": "[柳药股份]公司2018年度总结表彰暨2019年工作动员大会顺利召开",
    "href": "http://stock.jrj.com.cn/2019/03/03000027120385.shtml",
    "datetime": "2019-03-03 00:00:00",
    "code": "603368"
  },
  {
    "title": "[柳药股份]智变超越 使命担当——柳药股份2019年销售年会成功举办",
    "href": "http://stock.jrj.com.cn/2019/02/28000027101780.shtml",
    "datetime": "2019-02-28 00:00:00",
    "code": "603368"
  },
  {
    "title": "[柳药股份]公司2018年度总结表彰暨2019年工作动员大会顺利召开",
    "href": "http://stock.jrj.com.cn/2019/02/25000027101781.shtml",
    "datetime": "2019-02-25 00:00:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：2018年净利5.26亿元 同比增长31%",
    "href": "http://stock.jrj.com.cn/hotstock/2019/02/20075927064964.shtml",
    "datetime": "2019-02-20 07:59:58",
    "code": "603368"
  },
  {
    "title": "柳药股份2018年净利5.3亿增长31% 拟每10股转增4股",
    "href": "http://stock.jrj.com.cn/2019/02/20000527064116.shtml",
    "datetime": "2019-02-20 00:05:31",
    "code": "603368"
  },
  {
    "title": "柳药股份：2018年净利5.26亿元 同比增31%",
    "href": "http://stock.jrj.com.cn/2019/02/19161127062740.shtml",
    "datetime": "2019-02-19 16:11:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：非公开发行限售股上市流通公告",
    "href": "http://stock.jrj.com.cn/2019/02/12212027035578.shtml",
    "datetime": "2019-02-12 21:20:03",
    "code": "603368"
  },
  {
    "title": "柳药股份：已累计回购1.19%股份 耗资逾8200万元",
    "href": "http://stock.jrj.com.cn/hotstock/2019/02/12080027032697.shtml",
    "datetime": "2019-02-12 08:00:02",
    "code": "603368"
  },
  {
    "title": "柳药股份：已耗资逾8200万元回购1.19%股份",
    "href": "http://stock.jrj.com.cn/2019/02/11203827029418.shtml",
    "datetime": "2019-02-11 20:38:00",
    "code": "603368"
  },
  {
    "title": "[天眼]柳药股份副总唐贤荣超额减持 上交所监管关注",
    "href": "http://stock.jrj.com.cn/2019/01/16165226914207.shtml",
    "datetime": "2019-01-16 16:52:53",
    "code": "603368"
  },
  {
    "title": "[天眼]柳药股份副总经理违规减持被证监局警示",
    "href": "http://stock.jrj.com.cn/2019/01/08180926874253.shtml",
    "datetime": "2019-01-08 18:09:18",
    "code": "603368"
  },
  {
    "title": "柳药股份：预计带量采购对公司影响甚微",
    "href": "http://stock.jrj.com.cn/2018/12/11165525536862.shtml",
    "datetime": "2018-12-11 16:55:00",
    "code": "603368"
  },
  {
    "title": "柳药股份:目前参与投资设立有健康产业并购基金",
    "href": "http://stock.jrj.com.cn/2018/12/11141625531779.shtml",
    "datetime": "2018-12-11 14:16:49",
    "code": "603368"
  },
  {
    "title": "柳药股份：目前有参与投资设立健康产业并购基金",
    "href": "http://stock.jrj.com.cn/2018/12/11140425531618.shtml",
    "datetime": "2018-12-11 14:04:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：首次回购21.15万股 耗资637万元",
    "href": "http://stock.jrj.com.cn/hotstock/2018/12/05075925451582.shtml",
    "datetime": "2018-12-05 07:59:56",
    "code": "603368"
  },
  {
    "title": "[柳药股份]激发活力,团结奋进 ——广西柳州医药股份有限公司2018年职工气排球赛",
    "href": "http://stock.jrj.com.cn/2018/11/21000026798601.shtml",
    "datetime": "2018-11-21 00:00:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：2018年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2018/11/02214025298837.shtml",
    "datetime": "2018-11-02 21:40:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：2018年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/10/30080025277640.shtml",
    "datetime": "2018-10-30 08:00:36",
    "code": "603368"
  },
  {
    "title": "[柳药股份]公司获评“广西壮族自治区服务业品牌”称号",
    "href": "http://stock.jrj.com.cn/2018/10/25000026771722.shtml",
    "datetime": "2018-10-25 00:00:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：医药零售等高毛利业务增长较快",
    "href": "http://stock.jrj.com.cn/2018/10/23105525245571.shtml",
    "datetime": "2018-10-23 10:55:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：关于召开2018年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2018/10/17224025217746.shtml",
    "datetime": "2018-10-17 22:40:01",
    "code": "603368"
  },
  {
    "title": "柳药股份：拟斥资0.2亿—2亿元回购股份",
    "href": "http://stock.jrj.com.cn/hotstock/2018/10/17075925214277.shtml",
    "datetime": "2018-10-17 07:59:59",
    "code": "603368"
  },
  {
    "title": "[哈药股份]11亿,地方药商柳州医药收购中成药企业",
    "href": "http://stock.jrj.com.cn/2018/10/17000025215968.shtml",
    "datetime": "2018-10-17 00:00:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：第三届董事会第十三次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/10/16215025211891.shtml",
    "datetime": "2018-10-16 21:50:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：拟0.2亿至2亿元回购股份",
    "href": "http://stock.jrj.com.cn/2018/10/16195025211581.shtml",
    "datetime": "2018-10-16 19:50:00",
    "code": "603368"
  },
  {
    "title": "高溢价收购遭监管问询 柳药股份进军医药工业",
    "href": "http://stock.jrj.com.cn/2018/10/16053725206883.shtml",
    "datetime": "2018-10-16 05:37:48",
    "code": "603368"
  },
  {
    "title": "柳药股份：拟7.16亿元收购万通制药60%股权",
    "href": "http://stock.jrj.com.cn/hotstock/2018/10/01080025155946.shtml",
    "datetime": "2018-10-01 08:00:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：拟7亿元控股万通制药 加快布局药品生产领域",
    "href": "http://stock.jrj.com.cn/2018/09/28194025150942.shtml",
    "datetime": "2018-09-28 19:40:00",
    "code": "603368"
  },
  {
    "title": "柳药股份高管13日增持24564股 拟继续增持至多200万元",
    "href": "http://stock.jrj.com.cn/2018/09/13173325088078.shtml",
    "datetime": "2018-09-13 17:33:27",
    "code": "603368"
  },
  {
    "title": "柳药股份：深耕广西的批零一体化龙头",
    "href": "http://stock.jrj.com.cn/2018/08/28091525011985.shtml",
    "datetime": "2018-08-28 09:15:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：业绩增速远超医药流通行业",
    "href": "http://stock.jrj.com.cn/2018/08/23085824989645.shtml",
    "datetime": "2018-08-23 08:58:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：2018年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/08/20215024977345.shtml",
    "datetime": "2018-08-20 21:50:15",
    "code": "603368"
  },
  {
    "title": "柳药股份：第三届董事会第十一次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/08/20215024977346.shtml",
    "datetime": "2018-08-20 21:50:15",
    "code": "603368"
  },
  {
    "title": "柳药股份：上半年净利2.56亿元 同比增33%",
    "href": "http://stock.jrj.com.cn/2018/08/20191024976681.shtml",
    "datetime": "2018-08-20 19:10:00",
    "code": "603368"
  },
  {
    "title": "柳药股份：上半年净利2.56亿元 同比增长33%",
    "href": "http://stock.jrj.com.cn/hotstock/2018/07/25075924860145.shtml",
    "datetime": "2018-07-25 07:59:59",
    "code": "603368"
  },
  {
    "title": "柳药股份：上半年盈利2.56亿元 同比增长33%",
    "href": "http://stock.jrj.com.cn/2018/07/24192524857598.shtml",
    "datetime": "2018-07-24 19:25:00",
    "code": "603368"
  },
  {
    "title": "柳州医药逾1亿元收购友和古城39家门店资产",
    "href": "http://stock.jrj.com.cn/2018/06/03191824630397.shtml",
    "datetime": "2018-06-03 19:18:07",
    "code": "603368"
  },
  {
    "title": "柳州医药：设立孙公司收购友和古城39家门店",
    "href": "http://stock.jrj.com.cn/2018/06/03175024630276.shtml",
    "datetime": "2018-06-03 17:50:00",
    "code": "603368"
  },
  {
    "title": "柳州医药6月8日起更名为柳药股份",
    "href": "http://stock.jrj.com.cn/2018/06/01180024627015.shtml",
    "datetime": "2018-06-01 18:00:35",
    "code": "603368"
  },
  {
    "title": "柳州医药6月8日起更名为“柳药股份”",
    "href": "http://stock.jrj.com.cn/2018/06/01174224626901.shtml",
    "datetime": "2018-06-01 17:42:40",
    "code": "603368"
  },
  {
    "title": "柳州医药：证券简称6月8日起变更为“柳药股份”",
    "href": "http://stock.jrj.com.cn/2018/06/01173024626864.shtml",
    "datetime": "2018-06-01 17:30:00",
    "code": "603368"
  },
  {
    "title": "柳州医药更名为柳药股份",
    "href": "http://stock.jrj.com.cn/2018/05/22114524573310.shtml",
    "datetime": "2018-05-22 11:45:51",
    "code": "603368"
  },
  {
    "title": "柳州医药：证券简称拟变更为“柳药股份”",
    "href": "http://stock.jrj.com.cn/2018/05/21194024569811.shtml",
    "datetime": "2018-05-21 19:40:00",
    "code": "603368"
  },
  {
    "title": "柳州医药：两名高管拟减持股份",
    "href": "http://stock.jrj.com.cn/2018/05/17182024554867.shtml",
    "datetime": "2018-05-17 18:20:00",
    "code": "603368"
  },
  {
    "title": "柳州医药：今年计划新开不少于100家药店",
    "href": "http://stock.jrj.com.cn/2018/05/11162024527618.shtml",
    "datetime": "2018-05-11 16:20:00",
    "code": "603368"
  },
  {
    "title": "柳州医药：2017年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2018/05/02235024483328.shtml",
    "datetime": "2018-05-02 23:50:04",
    "code": "603368"
  },
  {
    "title": "柳州医药：2018年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/04/25003024443581.shtml",
    "datetime": "2018-04-25 00:30:05",
    "code": "603368"
  },
  {
    "title": "柳州医药：2017年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2018/04/11075024372271.shtml",
    "datetime": "2018-04-11 07:50:05",
    "code": "603368"
  },
  {
    "title": "柳州医药一季度净利润增逾35%",
    "href": "http://stock.jrj.com.cn/2018/04/09090524360354.shtml",
    "datetime": "2018-04-09 09:05:34",
    "code": "603368"
  },
  {
    "title": "柳州医药：年报净利4.01亿元 同比增25%",
    "href": "http://stock.jrj.com.cn/hotstock/2018/03/20080024264653.shtml",
    "datetime": "2018-03-20 08:00:02",
    "code": "603368"
  },
  {
    "title": "柳州医药：关于召开2017年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2018/03/20043024263799.shtml",
    "datetime": "2018-03-20 04:30:01",
    "code": "603368"
  },
  {
    "title": "柳州医药：年报净利增25% 拟10转4派6.6元",
    "href": "http://stock.jrj.com.cn/2018/03/19201024262648.shtml",
    "datetime": "2018-03-19 20:10:00",
    "code": "603368"
  },
  {
    "title": "柳州医药 流通份额显着提升 上下游渠道布局突破天花板 强烈推荐评级",
    "href": "http://stock.jrj.com.cn/2018/01/04105223895423.shtml",
    "datetime": "2018-01-04 10:52:00",
    "code": "603368"
  },
  {
    "title": "柳州医药：与龙潭医院签订战略合作协议",
    "href": "http://stock.jrj.com.cn/2017/12/19184223818716.shtml",
    "datetime": "2017-12-19 18:42:00",
    "code": "603368"
  },
  {
    "title": "柳州医药：与河池医院、桂林中医院签订《战略合作协议",
    "href": "http://stock.jrj.com.cn/hotstock/2017/11/28075923704851.shtml",
    "datetime": "2017-11-28 07:59:59",
    "code": "603368"
  },
  {
    "title": "[柳药股份]撸起袖子加油干——公司顺利召开2016年度总结表彰暨2017年工作动员大会",
    "href": "http://stock.jrj.com.cn/2017/02/07000025437995.shtml",
    "datetime": "2017-02-07 00:00:00",
    "code": "603368"
  },
  {
    "title": "柳州医药：携手广西医科大学第二附属医院 预计股价窄幅整理",
    "href": "http://stock.jrj.com.cn/2016/12/30204321913565.shtml",
    "datetime": "2016-12-30 20:43:43",
    "code": "603368"
  },
  {
    "title": "柳州医药股东周原九鼎披露减持计划",
    "href": "http://stock.jrj.com.cn/2016/09/01064121399218.shtml",
    "datetime": "2016-09-01 06:41:47",
    "code": "603368"
  },
  {
    "title": "柳州医药年报推10派6元 股权登记日5月9日",
    "href": "http://stock.jrj.com.cn/2016/05/03221220910437.shtml",
    "datetime": "2016-05-03 22:12:13",
    "code": "603368"
  },
  {
    "title": "柳州医药：非公开发行股票申请获证监会发行审核委员审",
    "href": "http://stock.jrj.com.cn/hotstock/2015/12/07075920192678.shtml",
    "datetime": "2015-12-07 07:59:59",
    "code": "603368"
  },
  {
    "title": "柳州医药：拟共调整3000万元设立两家全资子公司",
    "href": "http://stock.jrj.com.cn/hotstock/2015/10/20075919948957.shtml",
    "datetime": "2015-10-20 07:59:54",
    "code": "603368"
  },
  {
    "title": "柳州医药：签订战略合作协议",
    "href": "http://stock.jrj.com.cn/hotstock/2015/10/16075919935468.shtml",
    "datetime": "2015-10-16 07:59:54",
    "code": "603368"
  },
  {
    "title": "柳州医药：关于会计政策变更的公告",
    "href": "http://stock.jrj.com.cn/hotstock/2015/03/16075918966644.shtml",
    "datetime": "2015-03-16 07:59:59",
    "code": "603368"
  },
  {
    "title": "柳州医药：关于2015年度公司及控股子公司向 金融",
    "href": "http://stock.jrj.com.cn/hotstock/2015/03/16075918966645.shtml",
    "datetime": "2015-03-16 07:59:59",
    "code": "603368"
  },
  {
    "title": "柳州医药：关于2014年度关联交易执行情况的公告",
    "href": "http://stock.jrj.com.cn/hotstock/2015/03/16075918966646.shtml",
    "datetime": "2015-03-16 07:59:59",
    "code": "603368"
  },
  {
    "title": "维格娜丝和柳州医药两只新股中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2014/11/26195318427203.shtml",
    "datetime": "2014-11-26 19:53:31",
    "code": "603368"
  },
  {
    "title": "柳州医药：轻资产难抵高负债 IPO成救命稻草",
    "href": "http://stock.jrj.com.cn/ipo/2014/08/26105117885086.shtml",
    "datetime": "2014-08-26 10:51:18",
    "code": "603368"
  },
  {
    "title": "柳州医药IPO隐患重重 高负债率下圈钱解渴",
    "href": "http://stock.jrj.com.cn/ipo/2014/06/09133917366774.shtml",
    "datetime": "2014-06-09 13:39:03",
    "code": "603368"
  }
]